Clinical Trial Update: Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy

View source ↗

Summary

A completed clinical trial update examining the impact of immune activation on therapy response in head and neck squamous cell carcinoma, including oropharyngea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oropharyngeal Cancer

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Head and Neck Cancer, Oropharyngeal Cancer | Status: COMPLETED